These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3334418)

  • 41. Validation of new cancer biomarkers: a position statement from the European group on tumor markers.
    Duffy MJ; Sturgeon CM; Sölétormos G; Barak V; Molina R; Hayes DF; Diamandis EP; Bossuyt PM
    Clin Chem; 2015 Jun; 61(6):809-20. PubMed ID: 25882892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The highs and lows of tumor biomarkers: lost illusions.
    Melichar B
    Clin Chem Lab Med; 2015 Feb; 53(3):343-7. PubMed ID: 25720127
    [No Abstract]   [Full Text] [Related]  

  • 43. Recent advances in biosensor development for the detection of cancer biomarkers.
    Jayanthi VSPKSA; Das AB; Saxena U
    Biosens Bioelectron; 2017 May; 91():15-23. PubMed ID: 27984706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The potential of trefoil proteins as biomarkers in human cancer.
    May FE
    Biomark Med; 2012 Jun; 6(3):301-4. PubMed ID: 22731904
    [No Abstract]   [Full Text] [Related]  

  • 45. Interference by human antibodies with tumor marker assays.
    Reinsberg J
    Hybridoma; 1995 Apr; 14(2):205-8. PubMed ID: 7590781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical and immunologic diagnosis of cancer. Molecular probes and tumors in general.
    Sikora K
    Tumour Biol; 1987; 8(2-3):166-9. PubMed ID: 3329401
    [No Abstract]   [Full Text] [Related]  

  • 47. Regular review: tumour markers in malignancies.
    Lindblom A; Liljegren A
    BMJ; 2000 Feb; 320(7232):424-7. PubMed ID: 10669448
    [No Abstract]   [Full Text] [Related]  

  • 48. Cancer diagnosis: from tumor to liquid biopsy and beyond.
    Vaidyanathan R; Soon RH; Zhang P; Jiang K; Lim CT
    Lab Chip; 2018 Dec; 19(1):11-34. PubMed ID: 30480287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor Markers.
    Sölétormos G; Duffy MJ; Hayes DF; Sturgeon CM; Barak V; Bossuyt PM; Diamandis EP; Gion M; Hyltoft-Petersen P; Lamerz RM; Nielsen DL; Sibley P; Tholander B; Tuxen MK; Bonfrer JM
    Clin Chem; 2013 Jan; 59(1):52-9. PubMed ID: 23034139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioassay of saliva proteins: The best alternative for conventional methods in non-invasive diagnosis of cancer.
    Eftekhari A; Hasanzadeh M; Sharifi S; Dizaj SM; Khalilov R; Ahmadian E
    Int J Biol Macromol; 2019 Mar; 124():1246-1255. PubMed ID: 30513307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2010 Multidisciplinary Head and Neck Cancer Symposium.
    Huang SH; O'Sullivan B
    Expert Rev Anticancer Ther; 2010 May; 10(5):651-3. PubMed ID: 20469996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD44 as a potential diagnostic tumor marker.
    Basakran NS
    Saudi Med J; 2015 Mar; 36(3):273-9. PubMed ID: 25737167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycosylation markers in cancer.
    Silsirivanit A
    Adv Clin Chem; 2019; 89():189-213. PubMed ID: 30797469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Recent aspect of tumor markers in human report of Serono International Symposium].
    Urushizaki I; Maeda T
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):750-6. PubMed ID: 6191703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nucleic acid-based methods for the detection of cancer.
    Sidransky D
    Science; 1997 Nov; 278(5340):1054-9. PubMed ID: 9353179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer biomarker testing in the everyday practice of pathology.
    Cagle PT; Stein K; Oommen J; Shemon M; Kyle W
    Arch Pathol Lab Med; 2015 May; 139(5):583-4. PubMed ID: 25927145
    [No Abstract]   [Full Text] [Related]  

  • 57. Molecular Biomarkers of Disease for Diagnosis and Drug Development.
    Berisio R
    Curr Med Chem; 2019; 26(11):1922-1923. PubMed ID: 31293226
    [No Abstract]   [Full Text] [Related]  

  • 58. Proliferation markers in tumours: interpretation and clinical value.
    van Diest PJ; Brugal G; Baak JP
    J Clin Pathol; 1998 Oct; 51(10):716-24. PubMed ID: 10023332
    [No Abstract]   [Full Text] [Related]  

  • 59. [Biological markers of cancer. Critical study].
    Bellet D; Bidart JM
    Presse Med; 1993 Apr; 22(14):680-6. PubMed ID: 8511115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Soluble Fas and cancer.
    Owen-Schaub L
    Clin Cancer Res; 2001 May; 7(5):1108-9. PubMed ID: 11350870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.